Physician
The Pathology Group, INC.
The Pathology Group, INC. was paid $886K by Medicaid between Jan 2018 and Dec 2024, across 107 billing codes. Its largest line is 88305, Level IV - Surgical pathology, gross and microscopic examination — 9.5% of everything it billed.
33Billing provider infoTHE PATHOLOGY GROUP, INC.
FULLERTON, CA 92835
FULLERTON, CA 92835
33aNPI1316196892assigned 09/09/2008
33bProvider typeAnatomic Pathology & Clinical Pathology Physician
28Total paid$886K
24GClaims444,905
24DCodes billed107
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Anatomic Pathology & Clinical Pathology Physician providers in California
Rank by total paid#44 of 222
Median peer was paid$42K
This provider vs. median21×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 56,209 | $97K | |
| 2019 | 43,457 | $71K | |
| 2020 | 41,478 | $83K | |
| 2021 | 68,470 | $153K | |
| 2022 | 49,726 | $108K | |
| 2023 | 88,973 | $198K | |
| 2024incomplete | 96,592 | $177K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 9.5% | 3,169 | 3,007 | $84K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 9.4% | 65,318 | 42,136 | $83K |
| 80053 | Comprehensive metabolic panel | 8.1% | 44,201 | 31,300 | $71K |
| 83880 | 6.5% | 10,853 | 8,904 | $58K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 6.3% | 989 | 942 | $55K |
| 84145 | 5.2% | 11,677 | 10,323 | $46K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 4.8% | 30,604 | 16,456 | $43K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 3.8% | 1,589 | 1,543 | $34K |
| 84484 | 3.7% | 17,492 | 14,856 | $33K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 3.4% | 3,064 | 1,730 | $30K |
| 83735 | 3.1% | 22,130 | 7,711 | $27K | |
| 83605 | 2.9% | 14,609 | 12,088 | $26K |
95 more codes
| 84443 | Thyroid stimulating hormone (TSH) | 2.6% | 8,002 | $23K |
| 87040 | 2.2% | 7,665 | $19K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.0% | 487 | $17K |
| 83690 | 1.8% | 14,016 | $16K | |
| 85730 | 1.7% | 12,691 | $15K | |
| 80074 | 1.5% | 1,959 | $13K | |
| 85027 | 1.5% | 11,435 | $13K | |
| 82962 | 1.4% | 3,716 | $12K | |
| 80061 | Lipid panel | 1.4% | 5,807 | $12K |
| 85610 | 1.3% | 16,064 | $12K | |
| 84100 | 1.2% | 14,357 | $11K | |
| 81001 | 1.2% | 20,757 | $11K | |
| 82948 | 1.1% | 9,793 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.1% | 6,304 | $9K |
| 84703 | <1% | 6,681 | $8K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,515 | $7K |
| 80076 | <1% | 3,985 | $5K | |
| 85379 | <1% | 2,841 | $4K | |
| 82803 | <1% | 1,538 | $4K | |
| 88304 | <1% | 215 | $4K | |
| 81003 | <1% | 7,685 | $4K | |
| 82550 | <1% | 3,066 | $3K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 3,138 | $3K |
| 87077 | <1% | 2,086 | $3K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 917 | $3K |
| 86901 | <1% | 6,072 | $3K | |
| 84702 | <1% | 1,230 | $3K | |
| 86900 | <1% | 5,901 | $3K | |
| 82570 | <1% | 3,073 | $3K | |
| 85007 | <1% | 4,169 | $3K | |
| 87186 | <1% | 1,494 | $2K | |
| 82140 | <1% | 1,111 | $2K | |
| 86850 | <1% | 4,453 | $2K | |
| 85380 | <1% | 2,126 | $2K | |
| 84439 | <1% | 1,561 | $2K | |
| 82728 | <1% | 910 | $2K | |
| 88142 | <1% | 121 | $2K | |
| 87081 | <1% | 2,092 | $2K | |
| 82043 | <1% | 1,776 | $2K | |
| 86780 | <1% | 733 | $2K | |
| 82746 | <1% | 675 | $2K | |
| 83540 | <1% | 1,457 | $1K | |
| 87070 | <1% | 1,000 | $1K | |
| 83550 | <1% | 981 | $1K | |
| 81025 | <1% | 427 | $1K | |
| 80202 | <1% | 522 | $1K | |
| 85652 | <1% | 2,074 | $982.24 | |
| 84153 | <1% | 306 | $909.69 | |
| 83615 | <1% | 941 | $853.84 | |
| 86140 | <1% | 957 | $733.14 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 156 | $676.52 |
| 80047 | <1% | 584 | $641.65 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 143 | $625.54 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 748 | $621.15 |
| 82607 | <1% | 261 | $576.16 | |
| 82553 | <1% | 222 | $560.17 | |
| 87075 | <1% | 338 | $549.57 | |
| 87205 | <1% | 763 | $508.52 | |
| 86141 | <1% | 301 | $507.53 | |
| 82010 | <1% | 321 | $384.04 | |
| 86880 | <1% | 355 | $359.06 | |
| 87493 | <1% | 62 | $258.96 | |
| 84550 | <1% | 374 | $224.30 | |
| 89051 | <1% | 53 | $184.98 | |
| 84156 | <1% | 250 | $150.24 | |
| 88341 | <1% | 14 | $143.03 | |
| 82378 | <1% | 44 | $140.83 | |
| 88342 | <1% | 12 | $111.37 | |
| 85046 | <1% | 122 | $99.31 | |
| 87102 | <1% | 66 | $84.30 | |
| 84478 | <1% | 94 | $82.56 | |
| 83970 | <1% | 12 | $81.54 | |
| 87210 | <1% | 107 | $68.94 | |
| 84300 | <1% | 94 | $64.93 | |
| 86255 | <1% | 13 | $62.58 | |
| 86308 | <1% | 114 | $60.78 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 161 | $58.00 |
| 88311 | <1% | 12 | $55.88 | |
| 87147 | <1% | 72 | $51.07 | |
| 84154 | <1% | 14 | $41.30 | |
| 85014 | <1% | 110 | $35.42 | |
| 85018 | <1% | 113 | $35.01 | |
| 83874 | <1% | 13 | $32.67 | |
| 86592 | <1% | 41 | $27.49 | |
| 84479 | <1% | 26 | $26.29 | |
| 85347 | <1% | 24 | $21.18 | |
| 87116 | <1% | 14 | $19.66 | |
| 86706 | <1% | 13 | $18.79 | |
| 82150 | <1% | 15 | $16.75 | |
| 87045 | <1% | 13 | $13.94 | |
| 83930 | <1% | 13 | $13.54 | |
| 83935 | <1% | 12 | $11.75 | |
| 87899 | <1% | 12 | $10.88 | |
| 84436 | <1% | 14 | $10.38 | |
| 87046 | <1% | 13 | $8.96 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialBOONYASAMPANT, MARK (PRESIDENT)